Search - tctmd.com

Displaying 181 - 200 of 1118

Sort: Relevancy | Date

News Conference News STS 2023

Large Medicare Analysis Reopens Debate Over Multivessel Revascularization

Yael L. Maxwell

January 24, 2023

News Daily News

UK’s NICE Recommends Lower-Risk Thresholds for Statin Therapy

Michael O'Riordan

January 20, 2023

News Daily News

Sustained LDL-Cholesterol Reductions With Inclisiran: ORION-3

Michael O'Riordan

January 16, 2023

News Daily News

Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees

Michael O'Riordan

January 05, 2023

News Opinion Editor's Corner

The Biggest News of 2022: TCTMD’s Top 10

Shelley Wood

December 30, 2022

News Opinion Conversations in Cardiology

Conversations in Cardiology: ISCHEMIA’s Lasting Fallout

December 29, 2022

News Daily News

Top Coronary Artery Disease News of 2022

Yael L. Maxwell

December 29, 2022

News Daily News

Anatomic Disease After PCI Linked With Worse Outcomes: VA CART

Michael O'Riordan

December 22, 2022

News Daily News

ACS Care in Older Patients Entails Unique Risks, Shifting Goals, Says AHA

Todd Neale

December 16, 2022

News Daily News

Global Cardio-Oncology Viewpoints ‘Contextualize’ ESC Guidelines

L.A. McKeown

December 12, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2022

Caitlin E. Cox

December 01, 2022

News Daily News

Nuisance Bleeds on DAPT Not Just an Annoyance: TALOS-AMI Analysis

Caitlin E. Cox

November 30, 2022

News Daily News

P2Y12 Inhibitors Top Aspirin Following Post-PCI DAPT: Network Meta-analysis

Todd Neale

November 21, 2022

News Daily News

How Lp(a) Levels Compare With LDL-C in FH: Some Surprises

Michael O'Riordan

November 17, 2022

News Daily News

Many STEMI Patients Not Treated Within National Time Goals

Michael O'Riordan

November 15, 2022

News Conference News AHA 2022

RESPECT-EPA: Missed Primary Endpoint but Hints of Benefit With Icosapent Ethyl

Todd Neale

November 10, 2022

News Conference News AHA 2022

Another OPTION? Indobufen Noninferior to Aspirin Following Successful PCI

Yael L. Maxwell

November 10, 2022

News Conference News AHA 2022

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

Michael O'Riordan

November 06, 2022

News Conference News AHA 2022

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

Michael O'Riordan

November 06, 2022

Advertisement

Large Medicare Analysis Reopens Debate Over Multivessel Revascularization

UK’s NICE Recommends Lower-Risk Thresholds for Statin Therapy

Sustained LDL-Cholesterol Reductions With Inclisiran: ORION-3

Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees

The Biggest News of 2022: TCTMD’s Top 10

Conversations in Cardiology: ISCHEMIA’s Lasting Fallout

Top Coronary Artery Disease News of 2022

Anatomic Disease After PCI Linked With Worse Outcomes: VA CART

ACS Care in Older Patients Entails Unique Risks, Shifting Goals, Says AHA

Global Cardio-Oncology Viewpoints ‘Contextualize’ ESC Guidelines

TCTMD’s Top 10 Most Popular Stories for November 2022

Nuisance Bleeds on DAPT Not Just an Annoyance: TALOS-AMI Analysis

P2Y12 Inhibitors Top Aspirin Following Post-PCI DAPT: Network Meta-analysis

How Lp(a) Levels Compare With LDL-C in FH: Some Surprises

Many STEMI Patients Not Treated Within National Time Goals

RESPECT-EPA: Missed Primary Endpoint but Hints of Benefit With Icosapent Ethyl

Another OPTION? Indobufen Noninferior to Aspirin Following Successful PCI

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content